Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116891) titled 'A Clinical Study to Evaluate the Safety and Effectiveness of Qurs i Rewand Kabidi Compared with Atorvastatin in Patients with Dyslipidaemia' on Sept. 2.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Permuted block randomization, fixed Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Open Label
Primary Sponsor: National Research Institute of Unani Medicine for Skin Disorders
Condition:
Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified
...